Reckitt Benckiser Group (LSE: RB) suffered a disappointing third quarter, fallingshort of sales and revenue expectations.
Management has now trimmed its full-year revenue growth targets to the lower end of its 4% to 5% range, and is keener than ever to offload the struggling Reckitt Benckiser Pharmaceuticals, following its 9% drop in revenues.
UK-based investors have seen both companies as a great way to tap into faster growing emerging markets, but as Reckitts results show, manyregionshave been struggling lately.
Weak markets in south-east Asia and Latin America hit its revenues, and the company is also exposed to sanctions-hit Russia.
The US also underperformed after experiencing a tough year in 2014.
Sterlings recovery has proved another headwind, denting profits after they have been converted into pounds and pence.
All these problems are likely to surface at Unilever.
In fact, they have already. In July, managementcomplained that it was being hampered by the further slow-down in the emerging countries whilst developed markets are not yet picking up.
Troubles in Russia, China and Latin America all hit revenues, as has a stronger sterling. None of these trends have gone into reverse.
Low wage growth in the West, and the wider deflationary trend, will also hit sales and pricing at both companies. Consumers are hurting, and Reckitt Benckiser and Unilever will feel their pain.
Solid At The Back
Both companies have nonetheless lived up to their billing as defensive holdsduring the recent turbulence.
While the FTSE 100 is down 5% over the past year, Reckitt Benckiser grewnearly 6%, and Unilever returned 2%.
The downside of this is that they are expensive, with valuations way above the current FTSE 100 average of 13 times earnings.
Reckitt currently trades at a whopping20 times earnings, while Unilever isnt far behind at nearly 19 times earnings.
And while the FTSE 100 average yield has topped 3.6% following recent share price falls, Reckitt gives you a relatively lowly 2.75%. That is another blow to the investment case, along with the high price.
Unilever is slightly more tempting, yielding 3.63%.
You pay a high price for defensive solidity in days like these. NowI just wonder wherethe growth is coming from.
If you’re looking for income, you can getyields of 5% or 6% a year from the FTSE 100.
So why do savers put up with 1% or 2% on cash when FTSE 100 Dividends Now Thrash The Return On Cash?
Learn how you can tap into the wealth creating power of company dividends by downloading the Motley Fool’slatest special report How To Create Dividends For Life.
This no-obligation report demonstrates how reinvesting dividends for growth is the best way to build long-term wealth on the stock market. It is completely free so Click Here Now.
Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of Unilever. We Fools don’t all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.